April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Pharmacological Inhibition or Genetic Knockout of 5-LO Decreases Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy
Author Affiliations & Notes
  • A. Stahl
    Department of Ophthalmology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
  • P. Sapieha
    Department of Ophthalmology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
  • K. L. Willett
    Department of Ophthalmology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
  • K. M. Connor
    Department of Ophthalmology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
  • R. Dennison
    Department of Ophthalmology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
  • N. Krah
    Department of Ophthalmology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
  • C. M. Aderman
    Department of Ophthalmology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
  • J. Chen
    Department of Ophthalmology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
  • K. Gronert
    Center for Eye Disease and Development, School of Optometry, University of California, Berkeley, California
  • L. E. H. Smith
    Department of Ophthalmology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  A. Stahl, None; P. Sapieha, None; K.L. Willett, None; K.M. Connor, None; R. Dennison, None; N. Krah, None; C.M. Aderman, None; J. Chen, None; K. Gronert, None; L.E.H. Smith, None.
  • Footnotes
    Support  National Institutes of Health (EY008670, EY017017, EY14811 (L.E.H.S.); 1 F32 EY017789-01 (K.M.C.), the V. Kann Rasmussen Foundation (L.E.H.S), Juvenile Diabetes Research Foundation Int.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 2984. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Stahl, P. Sapieha, K. L. Willett, K. M. Connor, R. Dennison, N. Krah, C. M. Aderman, J. Chen, K. Gronert, L. E. H. Smith; Pharmacological Inhibition or Genetic Knockout of 5-LO Decreases Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy. Invest. Ophthalmol. Vis. Sci. 2009;50(13):2984.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Ocular neovascularization is the most common cause of blindness in all age groups. Previously, our lab demonstrated that this pathology is mediated in part through lipid based molecules. Omega3 long chain polyunsaturated fatty acids (omega3-LCPUFAs) are anti-angiogenic whereas omega6-LCPUFAs can aggravate neovascularization (NV) in a mouse model of oxygen-induced retinopathy. Both omega3- and omega6-LCPUFAs are substrates for the lipoxygenase (LO) pathway. LO constitutes a family consisting of 5-, 12-, or 15-LO which process eicosanoids into 5-, 12-, or 15-hydroxyeicosatetraenoic acid (HETE). These are transformed enzymatically into secondary products including leukotrienes and lipoxins which can act as signaling molecules.

Methods: : Retinopathy was induced in C57Bl/6 WT and 5-LO -/- mice through exposure to 75% oxygen from P7 to P12. After return to room air neovascularization (NV) was analyzed on P17 in 5-LO -/- mice and C57/Bl6 WT mice receiving the 5-LO inhibitor NDGA (25 µg/g/d). Expression of 5-LO and five lipoxygenase activating protein (FLAP) was studied using quantitative Real-time PCR and 5-HETE production was analyzed using LC/MS/MS-based lipidomics.

Results: : Expression of 5-LO as well as FLAP was elevated during the phase of pathologic retinal NV. Pharmacologic inhibition or genetic knockout of 5-LO decreased NV significantly. 5-LO gene expression did not change with dietary supplementation of omega3-LCPUFAs. However, the 5-LO metabolite 5-HETE was significantly reduced by omega3 supplementation.

Conclusions: : This data suggests that the downstream byproducts of the 5-LO pathway are important in modulating retinal angiogenesis. Pharmacologic inhibition or knockout of 5-LO signaling reduces hypoxia-induced neovascularization in the mouse retina. Our study suggests that omega3-LCPUFAs reduce the 5-LO metabolite 5-HETE, implying a functional role for 5-HETE in mediating the anti-angiogenic effect of omega3 supplementation.

Keywords: lipids • retinal neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×